You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Drug Price Trends for NDC 60505-0404


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 60505-0404

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
ARIPIPRAZOLE 1MG/ML SOLN,ORAL Golden State Medical Supply, Inc. 60505-0404-05 150ML 231.53 1.54353 2023-06-15 - 2028-06-14 FSS
ARIPIPRAZOLE 1MG/ML SOLN,ORAL Golden State Medical Supply, Inc. 60505-0404-05 150ML 245.83 1.63887 2023-06-23 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

60505-0404 Market Analysis and Financial Projection

Market Analysis and Price Projections for NDC 60505-0404

Introduction

The National Drug Code (NDC) 60505-0404 is associated with a specific pharmaceutical product, and understanding its market dynamics and price projections is crucial for stakeholders in the healthcare and pharmaceutical industries. Here, we will delve into the key aspects of market analysis and price projections for this NDC.

Understanding NDC 60505-0404

To begin with, it is essential to identify the drug associated with the NDC 60505-0404. While the specific drug name is not provided in the sources, understanding the general context of NDCs and their role in pharmaceutical billing and pricing is vital.

Market Trends in the Pharmaceutical Industry

The pharmaceutical industry is undergoing significant transformations driven by digital advancements, innovation, and changing regulatory landscapes.

  • Digital Transformation and Innovation: The life sciences industry is expected to see substantial growth in 2025, driven by digital transformation and scientific innovations. This includes the integration of technologies like gen AI and increased use of data to boost operational efficiencies and drive breakthrough innovations[3].

  • Pricing and Access: Pricing and access to drugs remain significant issues, with nearly half of C-suite executives expecting these factors to significantly impact their strategies in 2025. This trend highlights the ongoing challenges in drug pricing and reimbursement[3].

Pricing Dynamics

Pricing in the pharmaceutical industry is complex and influenced by various factors, including regulatory environments, market competition, and geopolitical uncertainties.

  • Global Price Comparisons: The average price per unit in the U.S. is significantly higher compared to other regions. For instance, in 2022, the average price per unit in the U.S. was 5.5 times as high as in the OECD (excluding the U.S.) and 7.7 times as high as the rest of the world (excluding the U.S.)[4].

  • Market Growth and Volume: The U.S. pharmaceutical market has seen substantial growth in sales revenues, particularly for biologic products, which grew by 61% in recent years. However, this growth is largely driven by higher prices rather than increased volume[4].

Price Projections for NDC 60505-0404

While specific price data for NDC 60505-0404 is not available in the provided sources, we can infer some trends from similar products and the broader market.

  • Premium Pricing for Innovative Therapies: If the drug associated with NDC 60505-0404 is an innovative therapy, it could follow premium pricing trends. This is common for drugs that offer significant therapeutic benefits and are often priced higher due to their innovative nature[2].

  • Impact of Generic and Biosimilar Competition: The pharmaceutical industry is facing increased competition from generic drugs and biosimilars. This competition can lead to price pressures, especially as patents expire and more generic or biosimilar alternatives become available. For example, the biopharma industry is facing a substantial loss of exclusivity, with over $300 billion in sales at risk through 2030 due to expiring patents[3].

Calculating NDC Units and Billing

For accurate billing and pricing, understanding how to calculate NDC units is crucial.

  • Manual Calculation: To calculate NDC units manually, one must consider the amount of the drug to be billed, the HCPCS/CPT code, and the NDC description. For instance, if the drug is a liquid solution, the amount billed must be converted from milligrams (MG) to milliliters (ML) based on the NDC description[1].

  • Using Online Tools: Many providers use online NDC units calculator tools to assist in converting HCPCS or CPT units to NDC units, ensuring accurate billing[1].

Market Size and Sales Revenue

The overall market size and sales revenue trends can provide insights into the potential pricing and demand for a specific drug.

  • Sales Revenue Growth: The U.S. pharmaceutical market has seen significant growth in sales revenues, particularly in the non-retail market (e.g., hospitals and physician offices). However, this growth is often driven by higher prices rather than increased volume[4].

  • Volume Growth: While sales revenues have grown, the volume growth in the U.S. has been relatively lower compared to other regions. This indicates that the average price per unit has increased over time[4].

Key Takeaways

  • Pricing and Access: Pricing and access remain critical issues in the pharmaceutical industry, influencing market strategies.
  • Innovation and Digital Transformation: The industry is poised for significant transformation driven by digital advancements and scientific innovations.
  • Global Price Disparities: Prices in the U.S. are significantly higher compared to other regions.
  • Competition from Generics and Biosimilars: Increased competition from generic drugs and biosimilars can impact pricing.
  • Accurate Billing: Calculating NDC units accurately is essential for proper billing and pricing.

FAQs

Q: What is the significance of NDC in pharmaceutical billing? A: The National Drug Code (NDC) is a unique identifier assigned to each medication, crucial for accurate billing and reimbursement in the healthcare system.

Q: How do global price disparities affect the pharmaceutical market? A: Global price disparities, with U.S. prices being significantly higher than in other regions, can impact market strategies and pricing models.

Q: What role does digital transformation play in the pharmaceutical industry? A: Digital transformation, including the use of gen AI and data analytics, is expected to boost operational efficiencies and drive breakthrough innovations in the industry.

Q: How does competition from generic and biosimilar drugs affect pricing? A: Competition from generic and biosimilar drugs can lead to price pressures, especially as patents expire and more alternatives become available.

Q: What are the key factors influencing price projections for pharmaceuticals? A: Key factors include innovative therapy status, regulatory environments, market competition, and geopolitical uncertainties.

Sources

  1. Billing with National Drug Codes (NDCs) Frequently Asked Questions - BCBSIL
  2. Latest drug prices and trends for NDC 60505-4478 - DrugPatentWatch
  3. 2025 life sciences outlook - Deloitte Insights
  4. International Market Size and Prices - ASPE
  5. NDC 60505-0749 Intramuscular - FDA.report

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.